Zentalis Pharmaceuticals (ZNTL) PT Lowered to $70 at Stifel, Keeps Buy with 'AstraZeneca Out Of The WEE1i Race'
Tweet Send to a Friend
Stifel analyst Bradley Canino lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $70.00 (from $72.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
